This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Ventana Medical Systems, Inc., The University of Arizona, University of Cincinnati. Active years: 2016-2021.
Company Filing History:
4 out of 548 
2 out of 1,055 
2 out of 556 
Years Active: 2016-2021
Title: Kristie A Vanpatten: Innovator in Cancer Prognosis
Introduction
Kristie A Vanpatten is a notable inventor based in Oro Valley, AZ (US). She has made significant contributions to the field of cancer research, particularly in the prognosis and treatment of various types of cancer. With a total of 4 patents, her work has the potential to impact patient care and therapeutic decisions.
Latest Patents
One of her latest patents is titled "Grading, staging, and prognosing cancer using osteopontin-c." This patent provides methods and kits that can be utilized to determine the grade or stage of breast cancer or other cancers, such as ductal carcinoma in situ (DCIS). By assessing the grade, stage, or aggressiveness of a cancer, appropriate therapeutic regimens can be selected and administered to patients. The method includes detecting osteopontin-c (OPN-c), where high levels of OPN-c in the cancer sample indicate a more aggressive form of cancer, such as grade 3.
Another significant patent is "Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration." This disclosure provides methods for characterizing a prostate cancer sample by detecting the expression of ERG, PTEN, or both. Changes in these expressions relative to a normal control are correlated with prostate cancer capsular penetration and more aggressive forms of the disease. These methods are crucial for prognosis and treatment decisions in patients with prostate cancer that has penetrated the capsule.
Career Highlights
Kristie has worked with prominent organizations, including Ventana Medical Systems, Inc. and the University of Arizona. Her experience in these institutions has allowed her to develop innovative solutions that address critical challenges in cancer diagnosis and treatment.
Collaborations
Some of her notable coworkers include Gary A Pestano and John K Hurley. Their collaborative efforts have contributed to advancing research in cancer prognosis and treatment methodologies.
Conclusion
Kristie A Vanpatten is a pioneering inventor whose work in cancer research has the potential to transform patient care. Her innovative patents and collaborations highlight her commitment to improving cancer prognosis and treatment options.